JPH01235582A - Novel pseudomonas bacteria - Google Patents
Novel pseudomonas bacteriaInfo
- Publication number
- JPH01235582A JPH01235582A JP6128588A JP6128588A JPH01235582A JP H01235582 A JPH01235582 A JP H01235582A JP 6128588 A JP6128588 A JP 6128588A JP 6128588 A JP6128588 A JP 6128588A JP H01235582 A JPH01235582 A JP H01235582A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- pseudomonas
- bacteria
- strains
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000589516 Pseudomonas Species 0.000 title claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 27
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 abstract description 12
- 239000001963 growth medium Substances 0.000 abstract description 3
- 230000003248 secreting effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 23
- 241000193830 Bacillus <bacterium> Species 0.000 description 10
- 239000002609 medium Substances 0.000 description 8
- 241000894007 species Species 0.000 description 7
- 241000589774 Pseudomonas sp. Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 108090000637 alpha-Amylases Proteins 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108050001049 Extracellular proteins Proteins 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000012770 industrial material Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- XDIYNQZUNSSENW-VXFWIXQWSA-N (2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanal;(2s,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O XDIYNQZUNSSENW-VXFWIXQWSA-N 0.000 description 1
- XHJCZVGOQPGVEW-RZVRUWJTSA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CCCNC(N)=N XHJCZVGOQPGVEW-RZVRUWJTSA-N 0.000 description 1
- 101150034533 ATIC gene Proteins 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-M D-glucopyranuronate Chemical compound OC1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-M 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-L D-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@H](O)C([O-])=O FEWJPZIEWOKRBE-LWMBPPNESA-L 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000009727 food gelling agent Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】 ものである。[Detailed description of the invention] It is something.
従来、一mに蛋白質を微生物によって生産させるという
場合、微生物を培養し、微生物国体を磨砕後、蛋白質を
抽出、精製することにより得ていた。Conventionally, when producing protein using microorganisms, it was obtained by culturing the microorganisms, grinding the microorganisms, and then extracting and purifying the proteins.
また、一般に遺伝子組換えの微生物生産の宿主としては
、大腸菌が主に使用されているが、大腸菌では、組換え
遺伝子によって合成されるペプチドや蛋白質は細砲内に
とどまり培地中に分泌生産されないため、自づとその生
産量は制限されていた。In addition, Escherichia coli is generally used as a host for genetically modified microorganism production, but in Escherichia coli, the peptides and proteins synthesized by recombinant genes remain in the cannon and are not secreted into the culture medium. However, the amount of production was naturally limited.
その上、細胞磨砕によりぺ1チド、蛋白質を抽出精製す
ることは、操作が煩雑になるなどの欠点が指摘されてい
る。Furthermore, it has been pointed out that extracting and purifying peptides and proteins by cell grinding has drawbacks such as complicated operations.
鵜高は、先に、遺伝子組換えにおける宿主菌として蛋白
質を菌体外に分泌する微生物を求めて研究した結果、蛋
白質を多量に分泌生産する微生物として、約1.200
株のなかからバチルス・プレビス(Bacillus
brevis) 4株、新菌株バチルス・プロテイホー
マンス(Bacillus proteifors+a
ns)1株の計5株を分離同定するに至った.[ Ag
ric.Biol。Udaka previously researched microorganisms that secrete proteins outside of their cells as host bacteria for genetic recombination, and found that approximately 1.200 microorganisms can secrete and produce large amounts of proteins.
Among the strains, Bacillus plebis
brevis) 4 strains, new strain Bacillus proteifors+a
A total of 5 strains, including 1 strain (ns), were isolated and identified. [Ag
ric. Biol.
Chem.、40 (3>、 523−528(197
6)]また、一R1分泌宿主−ベクターとして枯草口も
利用され、α−アミラーゼ、インターフェロンなど各種
異種蛋白質を培地中に蓄積させることに成功しているが
、菌体内外の強い10テアーゼにより生産量が制限され
たり、分解されたりして、良好な結果は得られていない
。Chem. , 40 (3>, 523-528 (197
6)] In addition, haystack has been used as a host-vector for R1 secretion, and various heterologous proteins such as α-amylase and interferon have been successfully accumulated in the culture medium. Good results have not been achieved due to limited amounts or decomposition.
先に、鵜高らは、バチルス・ステアロサーモフィルス(
Bacillus stearother++ophi
lus) DY−5の耐熱性α−アミラーゼ遺伝子をプ
ラスミド pυ811oに組込んだpRAM+01を保
有するバチルス プレビス47及び枯草菌と37℃、4
8時間培養した時、バチルス、フレヒス47テは約15
.0OOU/me 、枯草菌では3.000U/me程
度のα−アミラーゼをそれぞれ培地中に生産蓄積するの
を確認した。 [J、Bacteriol、、164
゜<3>、 1182−1187(1985)]ここに
、全く同一のプラスミドを保有するバチルス・プレビス
47と枯草菌とでは、耐熱性α−アミラーゼの生産にお
いてバチルス・プレビス47の方が約5倍も生産効率の
よいという事実から蛋白質生産国の有する蛋白質分泌能
を用いることにより異r4遺伝子産物を効率良く分泌生
産させうろことが判明した。Previously, Udaka et al.
Bacillus stearother++ophi
lus) Bacillus plevis 47 and Bacillus subtilis carrying pRAM+01 in which the thermostable α-amylase gene of DY-5 was integrated into plasmid pυ811o and Bacillus subtilis at 37°C.
When cultured for 8 hours, Bacillus and Frehiss 47 te were approximately 15
.. It was confirmed that approximately 000U/me of α-amylase was produced and accumulated in the medium, and for Bacillus subtilis it was approximately 3.000U/me. [J, Bacteriol,, 164
<3>, 1182-1187 (1985)] Here, between Bacillus plevis 47 and Bacillus subtilis, which carry exactly the same plasmid, Bacillus plevis 47 is approximately 5 times more efficient in producing heat-stable α-amylase. Based on the fact that the production efficiency is high, it has been found that the foreign r4 gene product can be secreted and produced efficiently by using the protein secretion ability possessed by protein producing countries.
そこで、本発明者らは、蛋白質を著量分泌しする菌が遺
伝子組換えにおける宿主菌としてすぐれたものであると
の発想から、このような菌株を求めて鋭意選別を行った
ところ、各種資料から分離した約 100.000株の
なかから菌体外に著量の蛋白質を生産する株を単層した
。Based on the idea that bacteria that secrete significant amounts of protein would be excellent host bacteria for genetic recombination, the inventors conducted a diligent selection process in search of such strains, and found various materials. Among the approximately 100,000 strains isolated from the bacteria, strains that produced a significant amount of protein outside the bacterial cells were placed in a monolayer.
ここに単離された株について、種の同定を行ったところ
、はとんどはバチルス属に−するものと同定された。When the strains isolated here were identified by species, most of them were identified as belonging to the genus Bacillus.
本発明者等は、更に鋭意選別を行ったところ、バチルス
属以外にも、蛋白質を著量に菌体外に分泌生産する菌株
を単離することに成功したのである。ここに単離された
株について、種の同定を行ったところ、シュードモナス
属に属するものと同定され、本発明を完成するに到った
。After further intensive selection, the present inventors succeeded in isolating a strain other than the genus Bacillus that secretes and produces a significant amount of protein outside the bacterial cell. When the species of the strain isolated here was identified, it was identified as belonging to the genus Pseudomonas, leading to the completion of the present invention.
本発明は、菌体外に著量の蛋白質を生産するシュードモ
ナス属菌である。The present invention relates to a Pseudomonas bacterium that produces a significant amount of protein extracellularly.
槌来、バチルス属において、蛋白質を生産するの株は知
られているが、シュードモナス属ωで蛋白質を5 ge
e以上もの著量菌体外に生産する菌株は知られていない
。Strains of the genus Bacillus that produce proteins are known, but strains of the genus Pseudomonas that produce proteins are known.
No bacterial strain is known that produces significantly more than e.
本発明においてはじめて分離された新菌株、即ち、1体
外に著量の蛋白質を生産するシュードモナス属の新菌株
は全く新規である。The new strain isolated for the first time in the present invention, ie, the new strain of the genus Pseudomonas that produces a significant amount of protein in vitro, is completely new.
本発明においては、蛋白質を5 g/I以上培地中に分
泌生産する菌株を目標に選択分離された。In the present invention, strains that secrete and produce 5 g/I or more of protein into the medium were selected and isolated.
まず、土壌などの試料から分離された約100.000
株の菌株をT2寒天平板培地(1%グルコース、1%ペ
プトン、0.5%内エキス、02%酵母エキス、15%
寒天末、pH7,0>に接種し、平板培地上でコロニー
周辺が5%過塩素酸により白濁する細菌を選択した0次
に、ここに分離したaaii株を12液体培地(150
n+e容三角フラスコ、培地量101)で振盪培養(3
0℃、48時間)し、その培養r液中に1.2gハ以上
の蛋白質を生産する菌株を80株得々菌体外蛋白質の測
定においては、培養液に等量の0.2N Na0)1を
加え攪拌?! 10.OOOrpm x 5分遠心分離
処理して菌体を除き、上清に等量の10%トリクロル酢
酸を加えて10分後3.OOOrpmx 10分間遠心
分離して沈殿を集め、IN NaOHで溶解したf&L
owry法[J、Biol、Chem、 193.26
5(1951)]によって定量し、蛋白質量は牛血清ア
ルブミンとして換算した。First, approximately 100,000
The strain was grown on T2 agar plate medium (1% glucose, 1% peptone, 0.5% yeast extract, 0.2% yeast extract, 15%
Agar powder, pH 7.0> was inoculated, and bacteria around the colony were selected to become cloudy with 5% perchloric acid on a plate medium.Next, the aaii strain isolated here was transferred to a liquid medium (150
Shake culture (3
0°C for 48 hours), and 80 strains producing 1.2g or more of protein were obtained in the culture solution.For the measurement of extracellular proteins, an equal amount of 0.2N Na0)1 was added to the culture solution. Add and stir? ! 10. Centrifuge at OOOrpm x 5 minutes to remove bacterial cells, add an equal volume of 10% trichloroacetic acid to the supernatant, and after 10 minutes, 3. OOOrpmx f&L was collected by centrifugation for 10 min and dissolved in IN NaOH.
owry method [J, Biol, Chem, 193.26
5 (1951)], and the protein amount was converted into bovine serum albumin.
蛋白質高生産培地として第1表に示す培地を選んだ。The media shown in Table 1 were selected as high protein production media.
第1表 蛋白質高生産培地
これらの5種類の培地のすべての培地に、先に得られた
80株の菌を14培養し、いずれがの培地で菌体外蛋白
質を5g/を以上生産する菌株を31株這択した。Table 1: High protein production medium 14 cultures of the 80 strains previously obtained were cultured in all of these 5 types of media, and which of the media produced 5 g or more of extracellular protein. We selected 31 stocks.
これら31株を、Bergey’s Manual o
f Determi−native Bacteri
ology (第8版) 、Bergey’Manua
l of 5ystea+atic Bacterio
ligy vol、1及び、TheProkaryot
e (A Handbook on )Iabitat
s。These 31 strains were analyzed using Bergey's Manual o
f Determi-native Bacteri
ology (8th edition), Bergey'Manua
l of 5ystea+atic Bacterio
ligy vol, 1 and TheProkaryot
e (A Handbook on)Iabitat
s.
l5olation and Identificat
ion of Bacteria)によって同定したと
ころ、6株は、まず、好気性、ダラム染色陰性、桿菌、
胞子を形成しない点においてシュードモナス属に属する
ものと認められたそのうち、8502株をその他の形態
的性質、各培地における生育状態、生理学的性質につい
て、シュードモナス属の従来知られている1種と比較検
討した結果、シュードモナス属のどの菌種とも異ってい
た。l5olation and identification
ion of Bacteria), the six strains were initially aerobic, Durham stain negative, bacilli,
Among the strains recognized as belonging to the genus Pseudomonas in that they do not form spores, 8502 strains were compared with one previously known species of the genus Pseudomonas on other morphological properties, growth conditions in various media, and physiological properties. The results showed that it was different from any other bacterial species in the genus Pseudomonas.
従って、本菌種はシュードモナス属の新菌種として同定
された。Therefore, this bacterial species was identified as a new bacterial species of the genus Pseudomonas.
かくて、本菌種はシュードモナスsp、H3O2と命名
された。シュードモナスsp、 8502はFERM
P−9743として微工研に寄託されている。Thus, this bacterial species was named Pseudomonas sp, H3O2. Pseudomonas sp, 8502 is FERM
It has been deposited with the Institute of Fine Technology as P-9743.
次にシュードモナスsp、 )+502の苗字的性質を
示す。Next, we will show the surname-like properties of Pseudomonas sp, )+502.
(A)形態的性質
(B)各培地における生育状態
(C)生理学的性質
つづきあり
(D>酸及びガスの生成
(E)炭素源の資化性
Acetate +5ucci
nate +Fu&1rate
−L−Malate
+β−Hydroxybutylate
+しactate
+C1trate +
*−Ketoglutarate −G
lycerol +L−Alan
ine +L−Asparta
te −L−Gluta+*ate
+L−Arginine
−L−Prol ine
+しTyrosine −D
−Fucose −
MalLose
−Cellobiose
−Lactose
−D−Arabinose
+5rbitol 十
5tarch ト
Inulin
−0xalate
−Ethylen glycol
−L−Threonine
−D−Ribose
+Mannitol
+D−Xylose
−L−Arabinose
−L−Rhamnose
−Glucose +
D−Mannose
−D−Galactose
−レ1lydroxyprol ine
)Inosine
+Betaine
−D−Fructose
−3ucrose 十
Treharose
−Gluconate
−Propionate
−Malonate
D(−)−Tartrate
+5orbitol
−Propyleneglycol 十
Ethanol +n
−Butanol +
Benzoate
−5−11ydroxybenzoate
−p−■ydroxybenzoate
−Phenol
−Glycine +
L−3erine
−L−Leucine
+L−1soleucine
−L−Valine
−L−Lysine ’ +
L−Ornithine +
L−Histidine
+L−Phenylalanine 十
L−Tryptophan +
N−Acety1glucosamine
+Raff1nose
+Creatine
+Deoxycholate
+D−Glucuronate
−本発明は、菌体外に著量の蛋白質を生産するシュ
ードモナス属菌で、特にシュードモナスsp。(A) Morphological properties (B) Growth status in each medium (C) Physiological properties (Continued) (D> Production of acid and gas (E) Assimilation of carbon source Acetate +5ucci
nate +Fu&1rate
-L-Malate
+β-Hydroxybutylate
+actate
+C1trate + *-Ketoglutarate -G
lycerol +L-Alan
ine +L-Aparta
te -L-Gluta+*ate
+L-Arginine
-L-Proline
+ Tyrosine -D
-Fucose-
MalLose
-Cellobiose
-Lactose
-D-Arabinose
+5 rbitol 15 tarch Inulin
-0xalate
-Ethylen glycol
-L-Threonine
-D-Ribose
+Mannitol
+D-Xylose
-L-Arabinose
-L-Rhamnose
-Glucose + D-Mannose
-D-Galactose
-Re1 lydroxyprol ine
)Inosine
+Betaine
-D-Fructose
-3ucrose 10Treharose
-Gluconate
-Propionate
-Malonate D(-)-Tartrate
+5orbitol
-Propylene glycol +n
-Butanol +
Benzoate
-5-11ydroxybenzoate
-p-■ydroxybenzoate
-Phenol
-Glycine + L-3erine
-L-Leucine
+L-1 soleucine
-L-Valine
-L-Lysine' +
L-Ornithine + L-Histidine
+L-Phenylanine 10L-Tryptophan +
N-Acety1glucosamine
+Raff1nose
+Create
+Deoxycholate
+D-Glucuronate
- The present invention relates to Pseudomonas bacteria that produce a significant amount of protein extracellularly, particularly Pseudomonas sp.
H3O2である。It is H3O2.
本発明のシュードモナス sp、 8502を培養する
ことにより著量生産した蛋白質の性質次第では、それ自
体食糧蛋白質やゲル化剤、膨化剤等の食品加工素材また
は、ガラス様素材、紙、人工皮革等の表面加工等の工業
素材としての利用等産業上の有用性が非常に高い。Depending on the properties of the protein produced in large amounts by culturing Pseudomonas sp. It has very high industrial utility, such as its use as an industrial material for surface finishing.
また、本発明のシュードモナスsp、 H3O2を遺伝
子組換えの宿主菌として利用した場合遺伝子聞損えによ
る生産物を効率良く菌体外に分泌することができるので
、遺伝子組換えにおける宿主菌としてきわめてすぐれた
ものになるであろう。Furthermore, when the Pseudomonas sp.H3O2 of the present invention is used as a host bacterium for genetic recombination, it is possible to efficiently secrete products resulting from gene damage to the outside of the bacterium, making it an excellent host bacterium for genetic recombination. It will become something new.
この系は、医素品、良質な食糧蛋白質やゲル化剤、膨化
剤等の食品加工素材または、ガラス様素材、紙、人工皮
革等の表面加工の工業素材などの生産手段としての活用
が期待できる。This system is expected to be used as a means of production for medical products, food processing materials such as high-quality food proteins, gelling agents, and leavening agents, and industrial materials for surface treatment such as glass-like materials, paper, and artificial leather. can.
以上のように本発明の有用性は産業上極めて;R深いも
のである。As described above, the usefulness of the present invention is extremely significant in industry.
以下に、実施例を挙げて本発明を更に具体的に説明する
。The present invention will be explained in more detail below by giving examples.
実施例1
前記第1表記載のIP培地500+++Iを2Q容のジ
ャーファーメンタ−に分注し、常法により 121℃2
0分滅菌した後、冷却した。Example 1 The IP medium 500+++I described in Table 1 above was dispensed into a 2Q volume jar fermenter, and heated to 121°C2 by a conventional method.
After sterilization for 0 minutes, it was cooled.
別に、IP培+1!5s+e分注した試験管をオートク
レーブすることにより滅菌し、これにシュードモナスs
p、H3O2を1白金耳摺種し、37℃で14時間振盪
培養した。この前培!I物51をジャーファーメンタ−
に接種し、37℃ 48時間通気量0.51/)回転数
400rp+++で培養した。培養終了後、培!!物に
等量ノo、2N NaOHを加え攪拌1k 1010
000rp 5分遠心分離処理して菌体を除き、1消1
00m1に笠醍の10zトリクロル酢酸を加え10分後
3000rpmX 10分間遠心分離して沈殿を集め
た。5%トリクロル酢酸で洗浄し、遠心分離に沈殿を集
めIN Na011で溶解したfiLowry法によっ
て電層した。蛋白質は牛血清アルブミンに換算して示し
た。その結果、1体外に生産された蛋白質量は78/脅
であった。Separately, the test tube containing the IP medium + 1!5 s + e was sterilized by autoclaving, and Pseudomonas s.
One platinum loop of p.p., H3O2 was inoculated and cultured with shaking at 37°C for 14 hours. Last time cultivated! Jarfur Mentor I thing 51
and cultured at 37° C. for 48 hours at an aeration rate of 0.51/) and a rotation speed of 400 rp+++. After culturing, cultivate! ! Add an equal amount of 2N NaOH to the product and stir 1k 1010
Centrifuge at 000 rpm for 5 minutes to remove bacterial cells.
10z trichloroacetic acid from Kasadai was added to 00ml, and after 10 minutes, the mixture was centrifuged at 3000 rpm for 10 minutes to collect the precipitate. The precipitate was washed with 5% trichloroacetic acid, collected by centrifugation, and electrolyzed by the fiLowry method, which was dissolved in IN Na011. Proteins are expressed in terms of bovine serum albumin. As a result, the amount of protein produced in vitro was 78/min.
Claims (1)
菌。A new Pseudomonas bacterium that produces a significant amount of protein outside the bacterial body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6128588A JPH01235582A (en) | 1988-03-15 | 1988-03-15 | Novel pseudomonas bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6128588A JPH01235582A (en) | 1988-03-15 | 1988-03-15 | Novel pseudomonas bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01235582A true JPH01235582A (en) | 1989-09-20 |
Family
ID=13166776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6128588A Pending JPH01235582A (en) | 1988-03-15 | 1988-03-15 | Novel pseudomonas bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01235582A (en) |
-
1988
- 1988-03-15 JP JP6128588A patent/JPH01235582A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Das et al. | Isolation, purification & mass production of protease enzyme from Bacillus subtilis | |
Pink et al. | Regulation of S-layer protein synthesis of Bacillus stearothermophilus PV72 through variation of continuous cultivation conditions | |
CN109913386B (en) | Tea tree endophyte CsE7 capable of producing theanine at high yield and application thereof | |
KR100530996B1 (en) | Method for Producing Bacterial Cellulose Using the Waste of Beer Fermentation Broth | |
Sneha et al. | Isolation and screening of protease producing bacteria from marine waste | |
EA037039B1 (en) | Strain of heterotrophic bacterium klebsiella pneumonia 1-17, associate for producing microbial protein mass | |
EP0257189A2 (en) | Novel Bacillus brevis strains and application thereof | |
RU2745093C1 (en) | Methylococcus capsulatus bf 19-07 methane-oxidizing bacteria strain - producer for obtaining microbial protein mass | |
JPH01235582A (en) | Novel pseudomonas bacteria | |
JPH11103855A (en) | Production of bacillus polyfermenticus by liquid fermentation | |
KR102295345B1 (en) | Mutant strain of gluconacetobacter hansenii having enhanced bacterial nano-cellulose productivity, and method for producing the bacterial nano-cellulose using the same | |
CN109554321B (en) | Genetically engineered bacterium for high-yield lipopeptide and application thereof | |
JPH01235585A (en) | Novel pseudomonas bacteria | |
JPH01235584A (en) | Novel pseudomonas bacteria | |
JPH01235583A (en) | Novel pseudomonas bacteria | |
JPH01235581A (en) | Novel pseudomonas bacteria | |
CN115820470B (en) | Bacillus amyloliquefaciens ZH804 and application thereof | |
JP4505620B2 (en) | Microorganism producing icosapentaenoic acid and method for producing icosapentaenoic acid | |
JP5528013B2 (en) | Alkaline protease high-producing bacteria | |
JPH01174378A (en) | Novel microorganism of genus pseudomonas | |
JPH08168389A (en) | Production of material secreted by organic matter using blue-green alga | |
JP4752024B2 (en) | Cell wall degrading enzyme, producing microorganism, and protoplast preparation method using the same | |
JPS6363375A (en) | Novel bacillus sp h023 | |
EP3467098A1 (en) | Aneurinibacillus migulanus | |
JP4002963B2 (en) | Megakaryocyte maturation substance, substance-producing microorganism and method for producing the substance |